Operating Data

Chembio Diagnostics, Inc. (CEMI)

$ 3.9
0.58 (+19.73%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 29.5527.6524.2617.8724.0233.4134.4630.4531.3232.2233.1434.0835.06
Revenue (%)
EBITDA 1.61-0.81-2.18-6.43-5.21-6.74-10.69-19.25-6.99-7.19-7.40-7.61-7.82
EBITDA (%)
EBIT 1-1.55-3.55-7.57-6.48-7.65-12.61-21.95-8.53-8.77-9.02-9.28-9.54
EBIT (%)
Depreciation 0.610.741.371.141.280.901.922.701.531.581.621.671.72
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)